- Home
- Services
- usa california
- clinical phase
Show results for
Refine by
Clinical Phase Services In Usa California
5 services found
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Our team of over fifty medical image processing scientists, including more than twenty PhDs, is responsible for extracting scientific quantitative data in support of Invicro’s studies from discovery research through late-phase clinical trials. The medical image analysis team blends cutting edge image science with proven image engineering capabilities to ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
While patients are typically advised to adhere to a lifelong gluten-free diet, inadvertent gluten consumption can still occur, causing symptoms and potentially severe health complications such as cancer or osteoporosis. The Phase 3 clinical trials for Latiglutenase are scheduled to start in late 2024, aiming for market release by 2027. This therapy could serve a ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s Advanced Pathology Services (APS) team provides end-to-end solutions to support translational and clinical research by providing a combination of routine and unique tissue testing services. As part of the REALM IDx, Inc. group, our pathology service laboratories support projects spanning preclinical biomarker discovery research to clinical trials and development of companion ...
Manufactured by:Advanced Brain Monitoring, Inc. based inCarlsbad, CALIFORNIA (USA)
Advanced Brain Monitoring provides full service EEG for clinical trials using the StatX Series wireless EEG systems administered concurrently with a full suite of tasks, including resting state and event-related related protocols. Stat X24 combines rapid application, low patient burden and disposable materials with high quality EEG acquisition easily performed in a clinical or home setting. Our ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...